Entity Details

Primary name PPBT_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP05186
EntryNamePPBT_HUMAN
FullNameAlkaline phosphatase, tissue-nonspecific isozyme
TaxID9606
Evidenceevidence at protein level
Length524
SequenceStatuscomplete
DateCreated1987-08-13
DateModified2021-06-02

Ontological Relatives

GenesALPL

GO terms

Show/Hide Table
GOName
GO:0001501 skeletal system development
GO:0001649 osteoblast differentiation
GO:0001958 endochondral ossification
GO:0003006 developmental process involved in reproduction
GO:0004035 alkaline phosphatase activity
GO:0005576 extracellular region
GO:0005886 plasma membrane
GO:0016020 membrane
GO:0016311 dephosphorylation
GO:0016462 pyrophosphatase activity
GO:0031012 extracellular matrix
GO:0031225 anchored component of membrane
GO:0032496 response to lipopolysaccharide
GO:0033280 response to vitamin D
GO:0046677 response to antibiotic
GO:0046872 metal ion binding
GO:0051384 response to glucocorticoid
GO:0065010 extracellular membrane-bounded organelle
GO:0070062 extracellular exosome
GO:0071407 cellular response to organic cyclic compound
GO:0071529 cementum mineralization

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR001952 Alkaline phosphataseFamilyFamily
IPR017850 Alkaline-phosphatase-like, core domain superfamilyFamilyHomologous superfamily
IPR018299 Alkaline phosphatase, active siteSiteActive site

Diseases

Show/Hide Table
Disease IDSourceNameDescription
146300 OMIMHypophosphatasia (HOPS)A metabolic bone disease characterized by defective skeletal mineralization and biochemically by deficient activity of the tissue non-specific isoenzyme of alkaline phosphatase. Four forms are distinguished, depending on the age of onset: perinatal, infantile, childhood and adult type. The perinatal form is the most severe and is almost always fatal. The adult form is mild and characterized by recurrent fractures, osteomalacia, rickets, and loss of teeth. Some cases are asymptomatic, while some patients manifest dental features without skeletal manifestations (odontohypophosphatasia). The disease is caused by variants affecting the gene represented in this entry.
241500 OMIMHypophosphatasia infantile type (HOPSI)A severe bone disease characterized by defective skeletal mineralization and biochemically by deficient activity of the tissue non-specific isoenzyme of alkaline phosphatase. Three more or less distinct types of infantile hypophosphatasia can be identified: (1) type 1 with onset in utero or in early postnatal life, craniostenosis, severe skeletal abnormalities, hypercalcemia, and death in the first year or so of life; (2) type 2 with later, more gradual development of symptoms, moderately severe 'rachitic' skeletal changes and premature loss of teeth; (3) type 3 with no symptoms, the condition being determined on routine studies. The disease is caused by variants affecting the gene represented in this entry.
241510 OMIMHypophosphatasia childhood type (HOPSC)A bone disease characterized by defective skeletal mineralization and biochemically by deficient activity of the tissue non-specific isoenzyme of alkaline phosphatase. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00165 PyridoxineDrugbanksmall molecule
DB01143 AmifostineDrugbanksmall molecule
DB06716 FospropofolDrugbanksmall molecule
DB09338 MersalylDrugbanksmall molecule
DB09498 Strontium chloride Sr-89Swissprotsmall molecule